Monday November 23 2009 | Biotechnology feed | All feeds
|
|
MolMed S.p.A.
Download detailed PDF Members: Since year 2000, MolMed has evolved into a biotechnology drug-developing company, with a primary focus on novel cancer therapies. Today, MolMed is an integrated company covering all functions, from discovery to proof of clinical efficacy.MolMed’s business strategy is based on five key points: Developing novel therapies by demonstrating proof of concept in small, well-defined patient populations with high unmet medical needs Extending the therapies to additional indications after clinical efficacy has been demonstrated Conducting late-stage clinical development of certain therapies for specialised indications Partnering with major biotech and pharma companies for late-stage clinical development and marketing of therapies for broader indications Assuring a constant supply of products in the pipeline through internal research, external research collaborations, and in-licensing
This page has been viewed 349 times since April 2007, the link to the organisation's website has been followed 86 times Search for more companies in Milan This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for MolMed S.p.A. | ||||||||||||||||||||||||||||||||||||||||||
|